Literature DB >> 29616346

In reply: Why remifentanil?

Wataru Sakai1, Yusuke Yoshikawa2, Michiaki Yamakage2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29616346     DOI： 10.1007/s00540-018-2487-7

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  3 in total

1.  Effect of remifentanil during cardiopulmonary bypass on incidence of acute kidney injury after cardiac surgery.

Authors:  Wataru Sakai; Yusuke Yoshikawa; Naoyuki Hirata; Michiaki Yamakage
Journal:  J Anesth       Date:  2017-10-30       Impact factor: 2.078

2.  Remifentanil temporarily improves renal function in adult patients with chronic kidney disease undergoing orthopedic surgery.

Authors:  Takerou Terashi; Akihiko Takehara; Tamotsu Kuniyoshi; Akira Matsunaga; Kouichi Kawasaki; Yuuichi Kanmura
Journal:  J Anesth       Date:  2013-02-15       Impact factor: 2.078

3.  Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?

Authors:  E Erkılıç; E Kesimci; F Alaybeyoğlu; I Kılınç; R Tural; A Yazgan; T Gümüş; A Sepici Dinçel; E G Dumlu; O Kanbak
Journal:  Drug Des Devel Ther       Date:  2017-03-08       Impact factor: 4.162
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.